Various reasons propel the chronic kidney disease (CKD) drug market growth throughout the different regions. These are: As per the most recent study of the chronic kidney disease (CKD) pharmaceuticals market, ...
HK inno.N said Monday that the approved indications for its SGLT-2 inhibitor diabetes drug Dapa.N (dapagliflozin) have been expanded to include chronic heart failure and chronic kidney disease. The market size of the dapagliflozin-based SGLT-2 inhibitors, which are well-known as weight-loss dia...
Chronic Kidney Disease Market - Global Analysis, Industry Segments and Forecast, 2014 - 2020TMR
Chronic kidney disease (CKD)—or chronic renal failure (CRF), as it was historically termed—is a term that encompasses all degrees of decreased renal function, from damaged–at risk through mild, moderate, and severe chronic kidney failure. CKD is a wor
Patients with chronic kidney disease (CKD) stages 1-3 (glomerular filtration rate [GFR] > 30 mL/min/1.73 m²) are frequently asymptomatic; in terms of possible “negative” symptoms related simply to the reduction in GFR, they do not experience clinically evident disturbances in water or ele...
Chronic kidney disease (CKD) has become a concerning public health issue, affecting people regardless of their sex, age, or socioeconomic status. We aimed to analyze the burden of female CKD in Mexico between 1990 and 2021, expressed in terms of years lived with disability (YLDs), mortality,...
Chronic kidney disease (CKD) is a growing global health issue, marked by a high mortality rate and significant cardiovascular risks. Despite advancements in treatment, a definitive cure remains out of reach, as current approaches mainly focus on managing underlying conditions. The progression of CKD...
Chronic kidney disease (CKD) demonstrates a complex interaction with tobacco exposure and sex differences, where females and males may experience varying risks and outcomes. This study aims to investigate how sex differences mediate the relationship betw
Moderate and Severe Chronic Kidney Disease Emerging Drugs Bardoxolone methyl: Reata Pharmaceuticals Bardoxolone methyl is an Nrf2 activator currently being investigated in clinical trials for the treatment of patients with different forms ...
Related to Chronic disease:Chronic kidney disease,Anemia of chronic disease one which is inveterate, of long continuance, or progresses slowly, in distinction from anacutedisease, which speedly terminates. See also:Chronic Webster's Revised Unabridged Dictionary, published 1913 by G. & C. Merriam ...